RGEN
Repligen Corporation
NASDAQ: RGEN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$113.11
-3.68% today
Updated 2026-04-29
Market cap
$6.38B
P/E ratio
131.52
P/S ratio
8.64x
EPS (TTM)
$0.86
Dividend yield
—
52W range
$110 – $176
Volume
0.9M
Repligen Corporation (RGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.62%
Operating margin
8.26%
ROE
2.40%
ROA
0.99%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $14.07M | $-889263.00 | 74.32% | -12.97% | -6.32% |
| 2007 | $19.30M | $37.11M | 68.08% | 186.00% | 192.30% |
| 2008 | $29.36M | $5.75M | 76.92% | 13.21% | 19.57% |
| 2009 | $20.97M | $-4.06M | 73.74% | -27.50% | -19.38% |
| 2010 | $27.29M | $-43509.00 | 73.92% | -1.37% | -0.16% |
| 2011 | $23.45B | $-1.61B | 72.40% | -4.72% | -6.88% |
| 2012 | $62.27M | $14.16M | 56.36% | 17.80% | 22.73% |
| 2013 | $68.17M | $16.09M | 63.09% | 33.55% | 23.61% |
| 2014 | $63.55M | $8.17M | 55.90% | 16.82% | 12.86% |
| 2015 | $83.54M | $9.35M | 57.80% | 16.48% | 11.19% |
| 2016 | $104.54M | $11.68M | 54.93% | 15.28% | 11.17% |
| 2017 | $141.24M | $28.35M | 52.53% | 9.92% | 20.07% |
| 2018 | $194.03M | $16.62M | 55.70% | 13.39% | 8.56% |
| 2019 | $270.25M | $21.41M | 51.15% | 14.83% | 7.92% |
| 2020 | $366.26M | $59.93M | 53.06% | 22.19% | 16.36% |
| 2021 | $670.53M | $128.29M | 58.35% | 24.94% | 19.13% |
| 2022 | $801.54M | $185.96M | 56.85% | 28.03% | 23.20% |
| 2023 | $638.76M | $41.58M | 44.50% | 8.54% | 6.51% |
| 2024 | $634.44M | $-25.51M | 43.29% | -5.53% | -4.02% |
| 2025 | $738.26M | $48.89M | 47.09% | 8.07% | 6.62% |